Literature DB >> 2082191

Growth hormone (GH) regulation of cytochrome P-450IIC12, insulin-like growth factor-I (IGF-I), and GH receptor messenger RNA expression in primary rat hepatocytes: a hormonal interplay with insulin, IGF-I, and thyroid hormone.

P Tollet1, B Enberg, A Mode.   

Abstract

We have studied the GH-dependent expression of cytochrome P-450IIC12 (P-450(15)beta) mRNA and insulin-like growth factor-I (IGF-I) mRNA in primary adult rat hepatocytes. The GH receptor (GHR), being the common denominator for the GH response, was also studied. The respective mRNA levels were measured with specific solution hybridization assays. By investigating the effects of insulin, IGF-I, T3, and corticosterone, alone or in combinations, in the presence or absence of GH we concluded that GH is indeed the inducer of P-450(15)beta mRNA and IGF-I mRNA. However, insulin and IGF-I exerted a 2-fold potentiation of the GH-induced expression of the P-450(15)beta and IGF-I mRNA species. No significant effect of insulin was observed on GHR mRNA expression, but a translational or posttranslational effect on GHR was seen, in that insulin increased the binding of GH to the cells 4-fold. Furthermore, T3 caused a 9-fold increase in the GH-induced expression of IGF-I mRNA. These observations led us to postulate a possible mechanism of hormonal interplay between GH, thyroid hormone, and IGF-I in vivo, i.e. a thyroid hormone potentiation of the GH-induced IGF-I expression, which, in turn, leads to an increased GHR level and thereby a potentiation of the GH-induced expression of P-450(15)beta and, at least transiently, of IGF-I. A transcriptional mechanism of GH action on P-450(15)beta and IGF-I mRNA induction was indicated by the similar half-lives of respective mRNAs in the presence or absence of GH in cell cultures treated with actinomycin-D.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2082191     DOI: 10.1210/mend-4-12-1934

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  9 in total

1.  Polymorphisms and DNA methylation level in the CpG site of the GHR1 gene associated with mRNA expression, growth traits and hormone level of half-smooth tongue sole (Cynoglossus semilaevis).

Authors:  J L Zhao; Y F Si; F He; H S Wen; J F Li; Y Y Ren; M L Zhao; Z J Huang; S L Chen
Journal:  Fish Physiol Biochem       Date:  2015-04-17       Impact factor: 2.794

2.  IRE-ABP (insulin response element-A binding protein), an SRY-like protein, inhibits C/EBPalpha (CCAAT/enhancer-binding protein alpha)-stimulated expression of the sex-specific cytochrome P450 2C12 gene.

Authors:  C Buggs; N Nasrin; A Mode; P Tollet; H F Zhao; J A Gustafsson; M Alexander-Bridges
Journal:  Mol Endocrinol       Date:  1998-09

Review 3.  Zonation of hepatic cytochrome P-450 expression and regulation.

Authors:  T Oinonen; K O Lindros
Journal:  Biochem J       Date:  1998-01-01       Impact factor: 3.857

4.  Expression of hepatocyte nuclear factor 6 in rat liver is sex-dependent and regulated by growth hormone.

Authors:  O Lahuna; L Fernandez; H Karlsson; D Maiter; F P Lemaigre; G G Rousseau; J Gustafsson; A Mode
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

5.  Growth hormone- and testosterone-dependent regulation of glutathione transferase subunit A5 in rat liver.

Authors:  L Staffas; E M Ellis; J D Hayes; B Lundgren; J W Depierre; L Mankowitz
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

6.  Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study.

Authors:  C Agnoli; F Berrino; C A Abagnato; P Muti; S Panico; P Crosignani; V Krogh
Journal:  Nutr Metab Cardiovasc Dis       Date:  2009-04-10       Impact factor: 4.222

7.  Exploring hepatic hormone actions using a compilation of gene expression profiles.

Authors:  Nina Ståhlberg; Roxana Merino; Luis Henríquez Hernández; Leandro Fernández-Pérez; Albin Sandelin; Pär Engström; Petra Tollet-Egnell; Boris Lenhard; Amilcar Flores-Morales
Journal:  BMC Physiol       Date:  2005-06-13

8.  Cyanocobalamin prevents cardiomyopathy in type 1 diabetes by modulating oxidative stress and DNMT-SOCS1/3-IGF-1 signaling.

Authors:  Masao Kakoki; Purushotham V Ramanathan; John R Hagaman; Ruriko Grant; Jennifer C Wilder; Joan M Taylor; J Charles Jennette; Oliver Smithies; Nobuyo Maeda-Smithies
Journal:  Commun Biol       Date:  2021-06-23

9.  Metabolic Syndrome and Breast Cancer Risk.

Authors:  Burhan Wani; Shiekh Aejaz Aziz; Mohammad Ashraf Ganaie; Mohammad Hussain Mir
Journal:  Indian J Med Paediatr Oncol       Date:  2017 Oct-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.